Sorafenib is effective for imatinib-resistant FIP1L1/PDGFRA T674I mutation-positive acute myeloid leukemia with eosinophilia

Arwa Z. Al-Riyami, Monika Hudoba, Sean Young, Donna Forrest

Research output: Contribution to journalArticle

6 Citations (Scopus)
Original languageEnglish
Pages (from-to)1788-1790
Number of pages3
JournalLeukemia and Lymphoma
Volume54
Issue number8
DOIs
Publication statusPublished - Aug 2013

Fingerprint

Phenylurea Compounds
Neoplasm Drug Resistance
mRNA Cleavage and Polyadenylation Factors
Piperazines
Benzamides
Platelet-Derived Growth Factor alpha Receptor
Pyrimidines
Niacinamide
Eosinophilia
Acute Myeloid Leukemia
Antineoplastic Agents
Mutation
sorafenib
Imatinib Mesylate

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Cite this

Sorafenib is effective for imatinib-resistant FIP1L1/PDGFRA T674I mutation-positive acute myeloid leukemia with eosinophilia. / Al-Riyami, Arwa Z.; Hudoba, Monika; Young, Sean; Forrest, Donna.

In: Leukemia and Lymphoma, Vol. 54, No. 8, 08.2013, p. 1788-1790.

Research output: Contribution to journalArticle

@article{8b09baa4440b40fc84d9fdc019d772fa,
title = "Sorafenib is effective for imatinib-resistant FIP1L1/PDGFRA T674I mutation-positive acute myeloid leukemia with eosinophilia",
author = "Al-Riyami, {Arwa Z.} and Monika Hudoba and Sean Young and Donna Forrest",
year = "2013",
month = "8",
doi = "10.3109/10428194.2012.749469",
language = "English",
volume = "54",
pages = "1788--1790",
journal = "Leukemia and Lymphoma",
issn = "1042-8194",
publisher = "Informa Healthcare",
number = "8",

}

TY - JOUR

T1 - Sorafenib is effective for imatinib-resistant FIP1L1/PDGFRA T674I mutation-positive acute myeloid leukemia with eosinophilia

AU - Al-Riyami, Arwa Z.

AU - Hudoba, Monika

AU - Young, Sean

AU - Forrest, Donna

PY - 2013/8

Y1 - 2013/8

UR - http://www.scopus.com/inward/record.url?scp=84880291638&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84880291638&partnerID=8YFLogxK

U2 - 10.3109/10428194.2012.749469

DO - 10.3109/10428194.2012.749469

M3 - Article

VL - 54

SP - 1788

EP - 1790

JO - Leukemia and Lymphoma

JF - Leukemia and Lymphoma

SN - 1042-8194

IS - 8

ER -